Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    20231565 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Condition: Type 2 Diabetes
Interventions: Drug: Salsalate;   Drug: Placebo
2 Recruiting Targeting Inflammation to Treat Cardiovascular Aging
Conditions: Vascular Stiffness;   Endothelial Dysfunction;   Diastolic Dysfunction
Interventions: Drug: Salsalate;   Drug: Placebo (for salsalate)
3 Completed
Has Results
Targeting Inflammation Using Salsalate for Type 2 Diabetes-stage II
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Salsalate;   Drug: Salsalate Placebo
4 Active, not recruiting Targeting Inflammation Using Salsalate in CardioVascular Disease
Conditions: Coronary Artery Disease;   Overweight
Interventions: Drug: Salsalate;   Drug: Placebo
5 Completed Using Salsalate to Target Adipocyte Macrophage Infiltration
Condition: Diabetes Risk
Interventions: Drug: Salsalate (4 g/day);   Drug: Placebo (4 g/day)

Indicates status has not been verified in more than two years